Suchergebnisse - "Filanovsky, Kalman"

PubPharm (35)

1

The Effect of The Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes A Study by the Israeli MDS Working Group

enthalten in: Acta haematologica | 2023

von Merkel, D. | Soffer, S. | Filanovsky, K. | +8

2

Vanishing bile duct syndrome in a patient with multiple myeloma treated with bortizomib, lenalidomide and dexamethasone

enthalten in: Clinics and research in hepatology and gastroenterology | 2023

von Filanovsky, K. | Temper, N. | Stanevsky, A. | +1

3

MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level

enthalten in: Journal of clinical medicine | 2023

von Haring, Y. | Goldschmidt, N. | Taha, S. | +20

4

Clonal Myeloid Dysplasia Following CAR T-Cell Therapy : Chicken or the Egg?

enthalten in: Cancers | 2023

von Vainstein, V. | Avni, B. | Grisariu, S. | +16

5

Raising the standards of patient-centered outcomes research in myelodysplastic syndromes : Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT project

enthalten in: Cancer medicine | 2023

von Efficace, F. | Koinig, K. | Cottone, F. | +14

6

Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes : Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project

enthalten in: Cancer Medicine | 2023

von Efficace, F. | Koinig, K. | Cottone, F. | +14

7

Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis

enthalten in: Annals of hematology | 2022

von Avivi, I. | Perry, C. | Segman, Y. | +26

8

Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL—a matched cohort analysis

enthalten in: Annals of hematology | 2022

von Avivi, I. | Perry, C. | Segman, Y. | +26

9

Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL—a matched cohort analysis

enthalten in: Annals of hematology | 2022

von Avivi, I. | Perry, C. | Segman, Y. | +26

10

Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy : real-life experience

enthalten in: Leukemia & lymphoma | 2021

von Segman, Y. | Ribakovsky, E. | Avigdor, A. | +22